RVMD
Revolution Medicines, Inc. · Healthcare
Chief Development Officer Alan B. Sandler sold $1.3M of Revolution Medicines, Inc.
Sold$1,275,294
$202.14Price
6,309Shares
−11%Stake
What RVMD did after the filing
- The stock from Fri, Oct 2 open, $205.89
- −9.2%
- S&P 500, same days
- −1.4%
15 of 30 trading days so far, to the Oct 23 close.
Traded Tue, Sep 29. Filed Thu, Oct 1, 6:00 PM ET, after the close. Returns use the Oct 2 open and the Oct 23 close. Not investment advice.